What is Origent Data Sciences?
Origent Data Sciences operates at the intersection of advanced machine learning and clinical research, providing a robust suite of tools designed to streamline the drug development lifecycle. By leveraging predictive modeling for patient recruitment and sophisticated clinical decision support systems, the company addresses critical inefficiencies in the treatment of neurodegenerative diseases. Their platform effectively bridges the gap between raw patient narratives and actionable clinical insights, offering pharmaceutical sponsors a mechanism to mitigate trial risks while simultaneously reducing operational expenditures. Through its AI-driven companion applications, the firm empowers both clinicians and patients, fostering a more data-centric approach to therapeutic intervention and long-term health monitoring.
How much funding has Origent Data Sciences raised?
Origent Data Sciences has raised a total of $128K across 1 funding round:
Debt
$128K
Debt (2021): $128K with participation from PPP
Key Investors in Origent Data Sciences
PPP
Public-Private Partnership
What's next for Origent Data Sciences?
With this recent influx of capital, Origent Data Sciences is well-positioned to accelerate its expansion into broader therapeutic areas and enhance its predictive diagnostic capabilities. The company is expected to prioritize the integration of its AI companion app into large-scale clinical trials, aiming to standardize the conversion of qualitative patient data into quantitative health metrics. As the firm matures, strategic focus will likely shift toward deepening partnerships with global pharmaceutical entities, further embedding their technology into the standard operating procedures of modern drug development. This trajectory suggests a sustained commitment to reducing the time-to-market for life-saving treatments while maintaining a competitive edge in the rapidly evolving health-tech sector.
See full Origent Data Sciences company page
